CF
GSK icon

Cantor Fitzgerald’s GSK GSK Stock Holding History

Cantor Fitzgerald’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-638,657
Closed -$23.7M – 295
2023
Q4 		$23.7M Buy
638,657
+630,390
+7,625% +$22.6M 4.86% 7
2023
Q3 		$300K Sell
8,267
-117,207
-93% -$4.16M 0.01% 399
2023
Q2 		$4.47M Sell
125,474
-138,527
-52% -$4.97M 0.1% 203
2023
Q1 		$9.39M Buy
+264,001
New +$9.24M 0.2% 172

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cantor Fitzgerald's GSK Position: Q1 2024 in Review

Cantor Fitzgerald sold out of GSK (GSK) in Q1 2024, closing a stake of 638,657 shares — an estimated $23.7M sold.

Cantor Fitzgerald first reported a position in GSK in Q1 2023 and held it in 4 quarters. The position peaked at $23.7M in Q4 2023. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Cantor Fitzgerald reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • Cantor Fitzgerald sold 638,657 GSK shares in Q1 2024, an estimated $23.7M.
  • Cantor Fitzgerald first reported a position in GSK in Q1 2023 and held it in 4 quarters.
  • Cantor Fitzgerald's GSK position peaked at $23.7M in Q4 2023.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Cantor Fitzgerald's 13F filing for Q1 2024, filed 15 May 2024.